𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic and pharmacodynamic studies with mitoxantrone in the treatment of patients with nasopharyngeal carcinoma

✍ Scribed by Oliver Yoa-Pu Hu; Shiu-Pei Chang; Chi-Kong Law; Jer-Min Jian; Kuang-Yao Chen


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
656 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Postradiation nasopharyngeal necrosis in
✍ Yi-Jun Hua; Ming-Yuan Chen; Chao-Nan Qian; Ming-Huang Hong; Chong Zhao; Ling Guo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 193 KB

## Abstract ## Background Radiation‐induced nasopharyngeal necrosis is a consequential late effect in the patients with nasopharyngeal carcinoma (NPC). Patients with NPC who have been treated with high‐dose radiotherapy are at risk of developing postradiation nasopharyngeal necrosis (PRNN). Howeve

Survival outcome of patients with nasoph
✍ Kwok Hung Yu; Sing Fai Leung; Stewart Yuk Tung; Benny Zee; Daniel T. T. Chua; Wa πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract ## Background. The purpose of this article is to report the overall survival (OS) outcome of patients with nasopharyngeal carcinoma (NPC) with local failure who received salvage treatment and to identify prognostic factors for OS. ## Methods. Between January 1996 and December 2000, 2

The time course of histologic remission
✍ Dora L. W. Kwong; John Nicholls; William I. Wei; Daniel T. T. Chua; Jonathan S. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 2 views

The objective of this study was to define the time course of histologic remission and to evaluate the prognostic significance of delayed histologic remission of patients with nasopharyngeal carcinoma (NPC).

A study of the pharmacokinetics and phar
✍ T. J. Fitzsimons; S. C. Norris; H. K. Adam; J. Ryan; J. McAinsh πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 469 KB πŸ‘ 2 views

This double-blind randomized, crossover study was undertaken to determine the pharmacokinetic properties of nifedipine retard and atenolol when given separately, as a free or a fixed combination, compared with placebo in 15 healthy male volunteers. There was no difference between the three atenolol